Detalles de la búsqueda
1.
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study.
BMC Gastroenterol
; 21(1): 398, 2021 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688250
2.
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis.
Lung Cancer
; 188: 107468, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181454
3.
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study.
Nat Med
; 30(3): 740-748, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302715
4.
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.
EClinicalMedicine
; 72: 102623, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800802
5.
Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer.
Front Oncol
; 13: 1124730, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998454
6.
Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).
Transl Lung Cancer Res
; 12(4): 786-796, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197631
7.
Silver nanocrystals mediated combination therapy of radiation with magnetic hyperthermia on glioma cells.
J Nanosci Nanotechnol
; 12(11): 8276-81, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23421206
8.
A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 inhibitors: a case report.
Ann Transl Med
; 10(16): 912, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111030
9.
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
BMJ
; 377: e068714, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440464
10.
Thermal analysis in the rat glioma model during directly multipoint injection hyperthermia incorporating magnetic nanoparticles.
J Nanosci Nanotechnol
; 11(12): 10333-8, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22408906
11.
Silver nanocrystals sensitize magnetic-nanoparticle-mediated thermo-induced killing of cancer cells.
Acta Biochim Biophys Sin (Shanghai)
; 43(4): 316-23, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21377996
12.
[Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Zhonghua Zhong Liu Za Zhi
; 33(6): 426-30, 2011 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-21875482
13.
Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer.
Chin J Cancer Res
; 23(2): 123-8, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23483517
14.
Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review.
Onco Targets Ther
; 14: 5363-5372, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34880628
15.
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Oral Oncol
; 119: 105369, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098386
16.
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12).
J Thorac Oncol
; 16(9): 1501-1511, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34048947
17.
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
Cancer Commun (Lond)
; 41(9): 889-903, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184418
18.
Long-term survival of an unresectable upper thoracic esophageal squamous cell carcinoma with severe dysphagia following nasogastric tube feeding and camrelizumab-containing therapy: a case report.
Transl Cancer Res
; 9(4): 3003-3006, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117657
19.
A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors.
Cancer Chemother Pharmacol
; 85(5): 907-915, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32266457
20.
Merkel cell carcinoma of the thigh: case report and review of the literature.
Onco Targets Ther
; 12: 535-540, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666132